Jeffrey Erickson

Jeffrey Erickson has a strong background in the pharmaceutical industry, with over 20 years of experience. Jeffrey has held various leadership roles in both finance and business development. Currently, they are serving as the Vice President of Business Development at Triumvira Immunologics, Inc. Prior to this, they worked as the Senior Director of Corporate Development at PhaseBio Pharmaceuticals, Inc. Jeffrey also has experience as a Senior Director of Finance & Business Development at Orexigen Therapeutics. Earlier in their career, they worked as an Analyst at Reneo Capital Management LP and as a Senior Product Manager at Arena Pharmaceuticals. Additionally, they have worked in the global forecasting department at Amgen and in finance, investor relations, forecasting, and market research at Amylin Pharmaceuticals. Jeffrey began their career as an Analyst at the MIT/Broad Institute, where they were a part of the Human Genome Project.

Jeffrey Erickson completed their Bachelor of Arts in Biochemistry from the University of Pennsylvania between the years 1997 and 2001.